Matthew Campobasso is General Counsel at Enfusion, Inc. (ENFN). They have made 7 open-market trades across 1 company since 2024, most recently 2025-04-21.
CIK 0002000984
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 7 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ENFN | 45,799 | $493K |
Shares reported on the most recent Form 4, priced at the 2025-04-21 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ENFN | SELL | 2025-03-05 | 2025-03-07 | $11.38 | $19K | +0.1% | -4.3% | N/A |
| ENFN | SELL | 2025-03-03 | 2025-03-05 | $11.48 | $12K | -2.7% | -6.9% | N/A |
| ENFN | SELL | 2025-01-07 | 2025-01-10 | $10.13 | $10K | +2.8% | +2.8% | -0.1% |
| ENFN | SELL | 2024-10-22 | 2024-10-24 | $8.95 | $6K | -0.7% | +11.7% | +23.3% |
| ENFN | SELL | 2024-06-18 | 2024-06-21 | $8.17 | $13K | +3.6% | +11.1% | +3.3% |
| ENFN | SELL | 2024-02-29 | 2024-03-04 | $8.73 | $943 | +9.2% | +9.9% | +8.0% |
| ENFN | SELL | 2024-01-08 | 2024-01-10 | $9.09 | $9K | +3.0% | -4.1% | +10.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.